DOCSLIB.ORG

The Survival of Filoviruses in Liquids, on Solid Substrates and in a Dynamic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Survival of Filoviruses in Liquids, on Solid Substrates and in a Dynamic Journal of Applied Microbiology ISSN 1364-5072 ORIGINAL ARTICLE The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol T.J. Piercy, S.J. Smither, J.A. Steward, L. Eastaugh and M.S. Lever Biomedical Sciences Department, Defence Science and Technology Laboratory, Salisbury, Wiltshire, UK Keywords Abstract aerosol, decay, ebola, filovirus, marburg, survival. Aims: Filoviruses are associated with high morbidity and lethality rates in humans, are capable of human-to-human transmission, via infected material Correspondence such as blood, and are believed to have low infectious doses for humans. Sophie J. Smither, Biomedical Sciences Filoviruses are able to infect via the respiratory route and are lethal at very low Department, Defence Science and Technology doses in experimental animal models, but there is minimal information on Laboratory, Room 201, Building 7a, Dstl, how well the filoviruses survive within aerosol particles. There is also little Porton Down, Salisbury, Wiltshire SP4 0JQ, UK. E-mail: [email protected] known about how well filoviruses survive in liquids or on solid surfaces which is important in management of patients or samples that have been exposed to 2010 ⁄ 0516: received 30 March 2010, revised filoviruses. 7 May 2010 and accepted 11 May 2010 Methods and Results: Filoviruses were tested for their ability to survive in dif- ferent liquids and on different solid substrates at different temperatures. The doi:10.1111/j.1365-2672.2010.04778.x decay rates of filoviruses in a dynamic aerosol were also determined. Conclusions: Our study has shown that Lake Victoria marburgvirus (MARV) and Zaire ebolavirus (ZEBOV) can survive for long periods in different liquid media and can also be recovered from plastic and glass surfaces at low temper- atures for over 3 weeks. The decay rates of ZEBOV and Reston ebolavirus (REBOV) plus MARV within a dynamic aerosol were calculated. ZEBOV and MARV had similar decay rates, whilst REBOV showed significantly better survival within an aerosol. Significance and Impact of the Study: Data on the survival of two ebolaviruses are presented for the first time. Extended data on the survival of MARV are presented. Data from this study extend the knowledge on the survival of filo- viruses under different conditions and provide a basis with which to inform risk assessments and manage exposure to filoviruses. to 100%) (Feldman et al. 1993; Feldman and Klenk Introduction 1996). The average lethality for humans is c. 76% for Viral haemorrhagic fevers can be caused by a range of ZEBOV and 57% for MARV (figures calculated from viral agents. The family Filoviridae consists of two genera, Bausch, et al. 2008) Both viruses are fast acting, with Ebolavirus and Marburgvirus, that contain filoviral species death often occurring within 7–10-day postinfection, (Zaire ebolavirus, Sudan ebolavirus and Bundibugyo ebola- although the incubation period is considered to be virus and Lake Victoria marburgvirus) that can cause acute 2–21 days (Peters and Khan 1999; Borio et al. 2002). To and rapidly progressive haemorrhagic fever in humans. date, the natural reservoir for filoviruses is not known; Two other Ebolavirus species, Cote d’Ivoire ebolavirus and however reports have shown that species of African fruit Reston ebolavirus, cause diseases in primates but are not bat may be the natural reservoir for the virus as antibod- pathogenic in humans. Zaire ebolavirus (ZEBOV) and ies to ZEBOV and MARV have been found in bat species, Lake Victoria marburgvirus (MARV) have been associated and human cases have been linked to bat exposure (Leroy with a number of outbreaks with high fatality rates (up et al. 2005; Pourrut et al. 2009; Towner et al. 2009). ª 2010 British Crown copyright 2010/DSTL – published with the permission of the Controller of Her Majesty’s Stationery Office Journal of Applied Microbiology 109, 1531–1539 ª 2010 The Society for Applied Microbiology 1531 Survival of filoviruses T.J. Piercy et al. Filoviruses are transmitted through contact with body Materials and methods fluids or tissues of humans, nonhuman primates or infected laboratory animals (Brown 1997; Mwanatambwe Virus stocks and containment et al. 2001; Pinzon et al. 2004). Historically, nosocomial transmission often occurs through the reuse of incorrectly ZEBOV strain E718, MARV strain Popp and REBOV were sterilized needles and syringes, or during nursing of an obtained from the Health Protection Agency, Porton infected individual through contact with blood, vomit or Down. ZEBOV strain E718 was a clinical isolate from the other infected secretions (Feldman and Klenk 1996). 1976 outbreak associated with a case fatality rate of 88% Transmission can also occur during burials and the prep- and was one of four isolates (including ZEBOV-Mayinga) aration of bodies for burial (Tukei 1996). taken from the original outbreak. MARV-Popp Filoviruses have been reported as being transmitted (Poppinga) was also a clinical isolate from the original via the aerosol route, either experimentally or within a outbreak in Germany in 1967. The REBOV stock used in biocontainment facility (Jaax et al. 1995; Johnson et al. aerosol decay experiments was originally obtained from 1995; Belanov et al. 1996) and are considered to be Fort Detrick (USAMRIID); however the passage history of potential biological warfare or bioterrorism agents the strain is unknown and is currently being sequenced. (Borio et al. 2002; Bray 2003). In addition, there are Solid and liquid survival studies were conducted with reports that MARV was previously weaponized (Alibek the two most pathogenic species (ZEBOV and MARV). and Handelman 1999). A recent review of persistence of REBOV was included in the aerosol survival studies as an Category A Select Agents in the environment highlighted apathogenic species for humans but associated with anec- how little basic information is known about the filo- dotal evidence of airborne transmission. The stock of viruses (Sinclair et al. 2008). The stability of MARV Sudan ebolavirus (strain Boniface) held at Dstl Porton within aerosols and dried on various substrates was Down has been shown to have an altered phenotype (less investigated by workers in the former Soviet Union virulent in immunodeficient mice) and to have under- (FSU) (Belanov et al. 1996; Chepurnov et al. 1997); gone substantial mutation, compared to stocks held by however survival characteristics of other filoviruses have the United States (J.E. Farlow and S.M. Ibrahim, personal not been investigated. communication, manuscript in preparation). In addition, In the United Kingdom, filoviruses are classified as there was poor recovery of Sudan ebolavirus upon aero- Advisory Committee on Dangerous Pathogens (ACDP) solization (M.S. Lever, unpublished observation), and Hazard Group 4 pathogens [equivalent to Biosafety therefore Sudan ebolavirus was not used in any studies Level 4 (BSL-4)] and are handled under laboratory con- presented here. tainment level 4 (CL4) to minimize the risk of infection All work was performed within primary containment to laboratory personnel. Filoviruses are also classed as facilities housed within ACDP CL4 laboratories at Dstl, Category A biological agents by the CDC as they have Porton Down. The majority of the work was performed high case fatality rates and are easily disseminated and either within an experimental laboratory consisting of a low infectious doses of filoviruses are sufficient to cause cabinet line of interconnected microbiological safety cabi- disease in animal models (Borio et al. 2002). In the nets (Lever et al. 2008) or interconnected rigid half-suit field, the infrastructure to handle the pathogens is not isolators (for aerosol studies). always available, and prevention of spread is reliant on good hygiene and removal of all contaminated and Microtitre TCID end-point dilution assay infectious material. It is unknown how long the filovi- 50 ruses are able to remain viable if waste and contami- African Green monkey kidney cell monolayers (Vero nated areas are not immediately sterilized. If the C1008) were prepared in 96-well microtitre plates (Nunc; filoviruses were aerosolized, either accidentally or as a Thermo Fisher, Basingstoke, UK) at a concentration of deliberate release, it is also unknown how long they 2 · 104 cells per well (Vero C1008 cells obtained from would survive as aerosols, and therefore how many peo- ECACC, catalogue number 85020206; Salisbury, UK) and ple might potentially be exposed. maintained in Dulbecco’s modified Eagle’s medium, Here, we provide data on the stability and viability of DMEM, supplemented with 10% foetal calf serum (FCS), MARV and ZEBOV in both liquid media and on a range and 1% penicillin, streptomycin and l-glutamine. Plates of solid substrates at various temperatures, over time. In were incubated overnight at 37°C in a 5% CO2-humidi- addition, the stability and decay rate of MARV, ZEBOV fied atmosphere, and 80-ll maintenance media (DMEM and Reston ebolavirus (REBOV) within small-particle plus 2% FCS, 1% HEPES and 1% penicillin, streptomycin aerosols held within a modified version of the Goldberg and l-glutamine) was added to columns 2–12 of the drum system (Goldberg et al. 1958) was investigated. plate. To column 1 of the plate, 100 ll of virus test ª 2010 British Crown copyright 2010/DSTL – published with the permission of the Controller of Her Majesty’s Stationery Office 1532 Journal of Applied Microbiology 109, 1531–1539 ª 2010 The Society for Applied Microbiology T.J. Piercy et al. Survival of filoviruses sample (from survival experiments) was added, and 20 ll and glass (glass coverslips, Fisher, Loughborough, UK). was transferred across the plate (1 : 10 dilution). Control A20ll suspension of virus was then dropped onto wells (columns 11 and 12) were left in maintenance 7 ml-diameter discs of plastic, metal or glass and media, and plates were incubated at 37°C in a 5% CO2- allowed to air-dry for 30 min. Discs were stored in humidified atmosphere. At 6-day postinfection, 3 ll (final individual tubes at either +4°C or room temperature at concentration of 1Æ5%) of neutral red stain (Sigma, Gil- a relative humidity of 55 ± 5% for the duration of the lingham, UK) was added to each well, and plates were study.
Load more

Recommended publications
  • Saint Louis Encephalitis Virus and Other Arboviruses in the Differential Diagnosis for Dengue
    Revista da Sociedade Brasileira de Medicina Tropical 47(5):541-542, Sep-Oct, 2014 http://dx.doi.org/10.1590/0037-8682-0197-2014 Editorial Saint Louis encephalitis virus and other arboviruses in the differential diagnosis for dengue Luiz Tadeu Moraes Figueiredo[1] [1]. Centro de Pesquisa em Virologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP. Brazil is a tropical country with a wide variety of flora and SLEV-seropositive by an immunoglobulin G-enzyme-linked fauna that includes many arthropods, especially mosquitoes and immunosorbent assay (IgG-ELISA), and these findings were midges. This ecological diversity facilitates the maintenance confirmed by a highly specific neutralization test. In the following of arboviral cycles and the emergence of novel arboviral year, during a widespread dengue type 3 epidemic, six patients pathogens. Indeed, many outbreaks attributable to zoonotic tested positive for SLEV in the City of São José do Rio Preto3,4. arboviruses such as Oropouche, Mayaro, Rocio virus (ROCV), Recently, a patient from Ribeirão Preto who presented with acute Saint Louis encephalitis virus (SLEV) and yellow fever virus febrile illness was also found to be SLEV-positive5. have been seen in the recent past. Furthermore, due to the In contrast to SLEV, ROCV has only been isolated in the increase in international travel, arboviruses present in other southeastern region of Brazil in the 1970s during a large-scale American countries, such as the emergent viruses West Nile outbreak of encephalitis that resulted in many fatalities. During and Chikungunya, have already been introduced, or could this outbreak, ROCV was isolated from 3 sources, a patient, be introduced to this region in the future.
    [Show full text]
  • A Multicenter, Multi-Outbreak, Randomized, Controlled Safety And
    2018 Ebola MCM RCT Protocol Page 1 of 92 IND#: 125530 CONFIDENTIAL 4 October 2019, version 7.0 A Multicenter, Multi-Outbreak, Randomized, Controlled Safety and Efficacy Study of Investigational Therapeutics for the Treatment of Patients with Ebola Virus Disease Short Title: 2018 Ebola MCM RCT Protocol Sponsored by: Office of Clinical Research Policy and Regulatory Operations (OCRPRO) National Institute of Allergy and Infectious Diseases 5601 Fishers Lane Bethesda, MD 20892 NIH Protocol Number: 19-I-0003 Protocol IND #: 125530 ClinicalTrials.gov Number: NCT03719586 Date: 4 October 2019 Version: 7.0 CONFIDENTIAL This document is confidential. No part of it may be transmitted, reproduced, published, or used by other persons without prior written authorization from the study sponsor and principal investigator. 2018 Ebola MCM RCT Protocol Page 2 of 92 IND#: 125530 CONFIDENTIAL 4 October 2019, version 7.0 KEY ROLES DRC Principal Investigator: Jean-Jacques Muyembe-Tamfum, MD, PhD Director-General, DRC National Institute for Biomedical Research Professor of Microbiology, Kinshasa University Medical School Kinshasa Gombe Democratic Republic of the Congo Phone: +243 898949289 Email: [email protected] Other International Investigators: see Appendix E Statistical Lead: Lori Dodd, PhD Biostatistics Research Branch, DCR, NIAID 5601 Fishers Lane, Room 4C31 Rockville, MD 20852 Phone: 240-669-5247 Email: [email protected] U.S. Principal Investigator: Richard T. Davey, Jr., MD Clinical Research Section, LIR, NIAID, NIH Building 10, Room 4-1479, Bethesda,
    [Show full text]
  • (SLE) Frequently Asked Questions What Is Saint Louis Encephalitis?
    Saint Louis Encephalitis (SLE) Frequently Asked Questions What is Saint Louis encephalitis? Saint Louis encephalitis (SLE) is a type of viral encephalitis (inflammation or swelling of the brain) caused by the Saint Louis encephalitis virus. The SLE virus is transmitted to humans by mosquitoes. This virus normally only circulates between birds and mosquitoes. Human‐biting mosquitoes can become infected, however, and can transmit this disease to people. These mosquitoes tend to live and breed in urban and suburban areas; most human cases are also found in these areas. Because of the life cycle of the mosquitoes that transmit SLE virus, most SLE infections occur in the late summer and in the fall. Saint Louis encephalitis is found throughout the United States, including Georgia. What are the symptoms of SLE? Most people do not become ill when a mosquito infected with the SLE virus bites them. People who do experience symptoms will start to feel ill approximately 5‐15 days after the mosquito bite. Most people who experience symptoms will only suffer from headaches or a mild flu‐like illness with muscle aches, weakness, or vomiting. A small number of persons may develop encephalitis or aseptic meningitis (inflammation/swelling of the protective covering of the brain and spinal cord), and may experience symptoms such as confusion, coma, and possibly death. How likely am I to have serious illness resulting from SLE infection? Less than 1% of persons infected with Saint Louis encephalitis virus will show symptoms. In children less than 10 years old, only 1 child out of 800 will experience symptoms.
    [Show full text]
  • Saint Louis Encephalitis (SLE)
    Encephalitis, SLE Annual Report 2018 Saint Louis Encephalitis (SLE) Saint Louis Encephalitis is a Class B Disease and must be reported to the state within one business day. St. Louis Encephalitis (SLE), a flavivirus, was first recognized in 1933 in St. Louis, Missouri during an outbreak of over 1,000 cases. Less than 1% of infections manifest as clinically apparent disease cases. From 2007 to 2016, an average of seven disease cases were reported annually in the United States. SLE cases occur in unpredictable, intermittent outbreaks or sporadic cases during the late summer and fall. The incubation period for SLE is five to 15 days. The illness is usually benign, consisting of fever and headache; most ill persons recover completely. Severe disease is occasionally seen in young children but is more common in adults older than 40 years of age, with almost 90% of elderly persons with SLE disease developing encephalitis. Five to 15% of cases die from complications of this disease; the risk of fatality increases with age in older adults. Arboviral encephalitis can be prevented by taking personal protection measures such as: a) Applying mosquito repellent to exposed skin b) Wearing protective clothing such as light colored, loose fitting, long sleeved shirts and pants c) Eliminating mosquito breeding sites near residences by emptying containers which hold stagnant water d) Using fine mesh screens on doors and windows. In the 1960s, there were 27 sporadic cases; in the 1970s, there were 20. In 1980, there was an outbreak of 12 cases in New Orleans. In the 1990s, there were seven sporadic cases and two outbreaks; one outbreak in 1994 in New Orleans (16 cases), and the other in 1998 in Jefferson Parish (14 cases).
    [Show full text]
  • Signature Redacted Signature of Author
    Developing VHH-based tools to study Ebolavirus Infection By Jason V. M. H. Nguyen B.S., Biochemistry and Molecular Biology University of California, Santa Cruz, 2012 Submitted to the Microbiology Graduate Program in partial fulfillment of the requirements for the degree of Doctor of Philosophy At the Massachusetts Institute of Technology June 2019 2019 Massachusetts Institute of Technology. All rights reserved. Signature redacted Signature of Author...... .................................................................... V Y' Jason V. M. H. Nguyen Microbiology Graduate Program May 13, 2019 Signature redacted Certified by.............. ................................................................... Hidde L. Ploegh Senior Investigator Boston Children's Hospital It Signature redacted Accepted by....... ......................................................................... Jacquin C. Niles Associate Professor of Biological Engineering Chair of Microbiology Program MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUN 2 12019 1 LIBRARIES ARCHIVES 2 Developing VHH-based tools to study Ebolavirus Infection By Jason V. M. H. Nguyen Submitted to the Microbiology Graduate Program on May 13th, 2019 in partial fulfillment of the requirements for the degree of Doctor of Philosophy ABSTRACT Variable domains of camelid-derived heavy chain-only antibodies, or VHHs, have emerged as a unique antigen binding moiety that holds promise in its versatility and utilization as a tool to study biological questions. This thesis focuses on two aspects on developing tools to study infectious disease, specifically Ebolavirus entry. In Chapter 1, I provide an overview about antibodies and how antibodies have transformed the biomedical field and how single domain antibody fragments, or VHHs, have entered this arena. I will also touch upon how VHHs have been used in various fields and certain aspects that remain underexplored. Chapter 2 focuses on the utilization of VHHs to study Ebolavirus entry using VHHs that were isolated from alpacas.
    [Show full text]
  • Rabbit Anti-Marburgvirus (MARV) VLP Pab ELISA Data
    4 Research Court, Suite 300 Rockville, MD 20850 877-411-2041 [email protected] Rabbit anti-Marburgvirus (MARV) VLP pAb ELISA Data: Catalog #: 04-0005 IgG IgG + IgG + Lot #: MMIG201001IBT Dilution MMARV ZEBOV 1:X Antigen Antigen Immunogen: MARV (Musoke strain) Virus-like Particles (VLPs) containing glycoprotein (GP) 1000 3.30 2.66 Nucleoprotein (NP), and viral protein (VP40). 3162 3.07 1.80 10000 2.68 0.89 Description: Protein A purified rabbit polyclonal 31623 1.87 0.37 antibody reactive to MARV VLP raised in New 100000 0.99 0.14 Zealand white rabbits. 316228 0.43 0.05 1000000 0.17 0.02 Supplied: 0.5 mg of antibody is supplied in PBS at a concentration of 5.75 mg/mL. 0.01% Sodium azide has been added. -Antigen is coated on ELISA plates overnight. -Add 200µl blocking buffer then wash wells with Clonality: Polyclonal PBST. -Antiserum is diluted semi-log. Relevance: the filovirus Marburgvirus is a -Incubate antibody for 2 hour. Category A (NIAID) and HHS select agent. -Wash unbound antibodies and add HRP- Recommended Dilutions: conjugated anti-rabbit IgG. -Wash plates and add substrate to develop color for ELISA: Assay-dependent dilution. 20 minutes. WB: Assay-dependent dilution -Read absorbance at 650nm. Amount of color is directly proportional to amount of antibodies. Storage: 2-3 weeks +4oC, -20◦C long term Western Blot Cross Reactivity: Historical data showed some cross-reactivity with Ebola Virus (EBOV) and -Antiserum recognizes Marburg musoke Sudan Virus (SUDV) VLP’s, most likely due to glycoprotein, nucleoprotein, and VP40 antibodies against Baculovirus proteins since the VLP’s were expressed in SF9-Baculovirus system.
    [Show full text]
  • 2019 Icar Program & Abstracts Book
    Hosted by the International Society for Antiviral Research (ISAR) ND International Conference 32on Antiviral Research (ICAR) Baltimore MARYLAND PROGRAM and USA Hyatt Regency BALTIMORE ABSTRACTS May 12-15 2019 ND TABLE OF International Conference CONTENTS 32on Antiviral Research (ICAR) Daily Schedule . .3 Organization . 4 Contributors . 5 Keynotes & Networking . 6 Schedule at a Glance . 7 ISAR Awardees . 10 The 2019 Chu Family Foundation Scholarship Awardees . 15 Speaker Biographies . 17 Program Schedule . .25 Posters . 37 Abstracts . 53 Author Index . 130 PROGRAM and ABSTRACTS of the 32nd International Conference on Antiviral Research (ICAR) 2 ND DAILY International Conference SCHEDULE 32on Antiviral Research (ICAR) SUNDAY, MAY 12, 2019 › Women in Science Roundtable › Welcome and Keynote Lectures › Antonín Holý Memorial Award Lecture › Influenza Symposium › Opening Reception MONDAY, MAY 13, 2019 › Women in Science Award Lecture › Emerging Virus Symposium › Short Presentations 1 › Poster Session 1 › Retrovirus Symposium › ISAR Award of Excellence Presentation › PechaKucha Event with Introduction of First Time Attendees TUESDAY, MAY 14, 2019 › What’s New in Antiviral Research 1 › Short Presentations 2 & 3 › ISAR Award for Outstanding Contributions to the Society Presentation › Career Development Panel › William Prusoff Young Investigator Award Lecture › Medicinal Chemistry Symposium › Poster Session 2 › Networking Reception WEDNESDAY, MAY 15, 2019 › Gertrude Elion Memorial Award Lecture › What’s New in Antiviral Research 2 › Shotgun Oral
    [Show full text]
  • How Severe and Prevalent Are Ebola and Marburg Viruses?
    Nyakarahuka et al. BMC Infectious Diseases (2016) 16:708 DOI 10.1186/s12879-016-2045-6 RESEARCHARTICLE Open Access How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence Luke Nyakarahuka1,2,5* , Clovice Kankya2, Randi Krontveit3, Benjamin Mayer4, Frank N. Mwiine2, Julius Lutwama5 and Eystein Skjerve1 Abstract Background: Ebola and Marburg virus diseases are said to occur at a low prevalence, but are very severe diseases with high lethalities. The fatality rates reported in different outbreaks ranged from 24–100%. In addition, sero-surveys conducted have shown different seropositivity for both Ebola and Marburg viruses. We aimed to use a meta-analysis approach to estimate the case fatality and seroprevalence rates of these filoviruses, providing vital information for epidemic response and preparedness in countries affected by these diseases. Methods: Published literature was retrieved through a search of databases. Articles were included if they reported number of deaths, cases, and seropositivity. We further cross-referenced with ministries of health, WHO and CDC databases. The effect size was proportion represented by case fatality rate (CFR) and seroprevalence. Analysis was done using the metaprop command in STATA. Results: The weighted average CFR of Ebola virus disease was estimated to be 65.0% [95% CI (54.0–76.0%), I2 = 97.98%] whereas that of Marburg virus disease was 53.8% (26.5–80.0%, I2 = 88.6%). The overall seroprevalence of Ebola virus was 8.0% (5.0%–11.0%, I2 = 98.7%), whereas that for Marburg virus was 1.2% (0.5–2.0%, I2 = 94.8%).
    [Show full text]
  • West Nile Virus Encephalitis Since The
    West Nile Virus Encephalitis Since the first United States occurrence of West Nile Virus (WNV) in New York in 1999, the virus has spread all the way down the East Coast, and as far west as Colorado and Nebraska. This Arbovirus belongs to the Japanese Encephalitis group along with Saint Louis Encephalitis. Arboviruses are vectored by mosquitoes; birds are the natural reservoir hosts. In other words, the virus replicates in birds, and is transmitted to others when a mosquito bites an infected bird and then passes the virus along during its next blood meal. Horses and humans are dead end hosts, meaning that they are not part of the viral replication cycle, and cannot directly pass the disease on to others. West Nile Virus produces lesions in the gray matter of the mid-brain, hind- brain, and spinal cord. Lesions tend to increase in severity the closer they are to the hindquarters. Lesions can be symmetrical or asymmetrical, effecting both or only one side of the horse. They can also be in more than one location, so combinations of clinical signs may vary. Clinical signs of West Nile Virus include fever (in about 60% of cases), muscle weakness, and neurologic problems including ataxia (staggering or incoordination), abnormal mental state (depression, lethargy, behavior changes), and muscle fasiculations (trembling) of the head and neck. Some cranial nerves may also be involved producing drooping of the facial muscles, difficulty swallowing, and problems with normal tongue function. Any number and combination of these signs is possible. Prognosis is variable, and depends on severity of clinical signs, and prompt veterinary attention.
    [Show full text]
  • Development of an Antibody Cocktail for Treatment of Sudan Virus Infection
    Development of an antibody cocktail for treatment of Sudan virus infection Andrew S. Herberta,b, Jeffery W. Froudea,1, Ramon A. Ortiza, Ana I. Kuehnea, Danielle E. Doroskya, Russell R. Bakkena, Samantha E. Zaka,b, Nicole M. Josleyna,b, Konstantin Musiychukc, R. Mark Jonesc, Brian Greenc, Stephen J. Streatfieldc, Anna Z. Wecd,2, Natasha Bohorovae, Ognian Bohorove, Do H. Kime, Michael H. Paulye, Jesus Velascoe, Kevin J. Whaleye, Spencer W. Stoniera,b,3, Zachary A. Bornholdte, Kartik Chandrand, Larry Zeitline, Darryl Sampeyf, Vidadi Yusibovc,4, and John M. Dyea,5 aVirology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702; bThe Geneva Foundation, Tacoma, WA 98402; cFraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711; dDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461; eMapp Biopharmaceutical, Inc., San Diego, CA 92121; and fBioFactura, Inc., Frederick, MD 21701 Edited by Y. Kawaoka, University of Wisconsin–Madison/University of Tokyo, Madison, WI, and approved December 30, 2019 (received for review August 28, 2019) Antibody-based therapies are a promising treatment option for antibody-based immunotherapies. Subsequently, several indepen- managing ebolavirus infections. Several Ebola virus (EBOV)-specific dent groups reported the postexposure efficacy of monoclonal and, more recently, pan-ebolavirus antibody cocktails have been antibody (mAb)-based immunotherapies against EVD in ma- described. Here, we report the development and assessment of a caques when administered as mixtures of two or more mAbs (14–17). Sudan virus (SUDV)-specific antibody cocktail. We produced a panel These landmark studies demonstrated that combination mAb- of SUDV glycoprotein (GP)-specific human chimeric monoclonal based immunotherapies are a viable treatment option for EVD antibodies (mAbs) using both plant and mammalian expression and spurred therapeutic antibody development for filoviruses.
    [Show full text]
  • Understanding Ebola
    Understanding Ebola With the arrival of Ebola in the United States, it's very easy to develop fears that the outbreak that has occurred in Africa will suddenly take shape in your state and local community. It's important to remember that unless you come in direct contact with someone who is infected with the disease, you and your family will remain safe. State and government agencies have been making preparations to address isolated cases of infection and stop the spread of the disease as soon as it has been positively identified. Every day, the Centers of Disease Control and Prevention (CDC) is monitoring developments, testing for suspected cases and safeguarding our lives with updates on events and the distribution of educational resources. Learning more about Ebola and understanding how it's contracted and spread will help you put aside irrational concerns and control any fears you might have about Ebola severely impacting your life. Use the resources below to help keep yourself calm and focused during this unfortunate time. Ebola Hemorrhagic Fever Ebola hemorrhagic fever (Ebola HF) is one of numerous Viral Hemorrhagic Fevers. It is a severe, often fatal disease in humans and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Ebola HF is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. When infection occurs, symptoms usually begin abruptly. The first Ebolavirus species was discovered in 1976 in what is now the Democratic Republic of the Congo near the Ebola River. Since then, outbreaks have appeared sporadically. There are five identified subspecies of Ebolavirus.
    [Show full text]
  • Taï Forest Virus Does Not Cause Lethal Disease in Ferrets
    microorganisms Article Taï Forest Virus Does Not Cause Lethal Disease in Ferrets Zachary Schiffman 1,2,† , Feihu Yan 3,†, Shihua He 2, Kevin Tierney 2, Wenjun Zhu 2 , Karla Emeterio 1,2, Huajun Zhang 1, Logan Banadyga 2,* and Xiangguo Qiu 2 1 Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; [email protected] (Z.S.); [email protected] (K.E.); [email protected] (H.Z.) 2 Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; [email protected] (S.H.); [email protected] (K.T.); [email protected] (W.Z.); [email protected] (X.Q.) 3 Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130122, China; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Filoviruses are zoonotic, negative-sense RNA viruses, most of which are capable of causing severe disease in humans and nonhuman primates, often with high case fatality rates. Among these viruses, those belonging to the Ebolavirus genus—particularly Ebola virus, Sudan virus, and Bundibugyo virus—represent some of the most pathogenic to humans. Taï Forest virus (TAFV) is thought to be among the least pathogenic ebolaviruses; however, only a single non-fatal case has been documented in humans, in 1994. With the recent success of the ferret as a lethal model for a number of ebolaviruses, we set out to evaluate its suitability as a model for TAFV. Our results demonstrate that, unlike other ebolaviruses, TAFV infection in ferrets does not result in lethal disease.
    [Show full text]